SEC Form 4 · accession 0001104659-16-112536
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Gilmore
Officer — General Counsel
Period of report
Apr 18, 2016
Accepted (ET)
Apr 19, 2016 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.46 | Apr 18, 2016 | A | 30,000 | A | — | Apr 17, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option was granted on April 18, 2016. 25% of the shares subject to the stock option vest on April 18, 2017, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on April 18, 2020.